Simone Badal

574 total citations
25 papers, 369 citations indexed

About

Simone Badal is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Simone Badal has authored 25 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Pharmacology and 6 papers in Oncology. Recurrent topics in Simone Badal's work include Microbial Natural Products and Biosynthesis (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Fungal Biology and Applications (3 papers). Simone Badal is often cited by papers focused on Microbial Natural Products and Biosynthesis (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Fungal Biology and Applications (3 papers). Simone Badal collaborates with scholars based in Jamaica, United States and Kenya. Simone Badal's co-authors include Rupika Delgoda, Rajendram V. Rajnarayanan, Ngeh J. Toyang, Henry Lowe, Henkel Valentine, Tzuen‐Rong Tzeng, Keriayn N. Smith, Joseph Bryant, Winklet A. Gallimore and Camille Ragin and has published in prestigious journals such as Nature reviews. Cancer, Pharmacology & Therapeutics and Phytochemistry.

In The Last Decade

Simone Badal

25 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simone Badal Jamaica 13 152 67 65 59 51 25 369
Sudhandiran Ganapasam India 11 246 1.6× 58 0.9× 53 0.8× 84 1.4× 63 1.2× 15 460
Violetta Mohos Hungary 14 148 1.0× 81 1.2× 138 2.1× 53 0.9× 76 1.5× 18 424
Ramakrishna Chintala India 4 220 1.4× 44 0.7× 46 0.7× 71 1.2× 33 0.6× 7 431
Nan Sun China 8 221 1.5× 52 0.8× 31 0.5× 46 0.8× 48 0.9× 14 421
Yun-Sil Lee South Korea 5 232 1.5× 83 1.2× 42 0.6× 64 1.1× 50 1.0× 6 496
In Gyeong Chae South Korea 11 167 1.1× 36 0.5× 57 0.9× 31 0.5× 44 0.9× 17 340
Anna Maidecchi Italy 14 148 1.0× 44 0.7× 28 0.4× 36 0.6× 82 1.6× 18 354
Serena Pantalone Italy 5 201 1.3× 67 1.0× 33 0.5× 55 0.9× 28 0.5× 5 361
Uteuliyev Yerzhan Sabitaliyevich Kazakhstan 13 279 1.8× 49 0.7× 60 0.9× 50 0.8× 60 1.2× 36 512
Elbert L. Myles United States 10 150 1.0× 42 0.6× 49 0.8× 47 0.8× 39 0.8× 19 441

Countries citing papers authored by Simone Badal

Since Specialization
Citations

This map shows the geographic impact of Simone Badal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone Badal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone Badal more than expected).

Fields of papers citing papers by Simone Badal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone Badal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone Badal. The network helps show where Simone Badal may publish in the future.

Co-authorship network of co-authors of Simone Badal

This figure shows the co-authorship network connecting the top 25 collaborators of Simone Badal. A scholar is included among the top collaborators of Simone Badal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone Badal. Simone Badal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Plummer, Jasmine, et al.. (2024). Failure to progress: breast and prostate cancer cell lines in developing targeted therapies. Cancer and Metastasis Reviews. 43(4). 1529–1548. 1 indexed citations
2.
Chin, Sheray N., et al.. (2022). Racial disparities in breast cancer preclinical and clinical models. Breast Cancer Research. 24(1). 56–56. 11 indexed citations
3.
Badal, Simone. (2022). Ethnically diverse cancer cell lines for drug testing. Nature reviews. Cancer. 22(2). 65–66. 1 indexed citations
4.
Zhao, Ziran, Henkel Valentine, Zemin Liu, et al.. (2020). Immortalization of human primary prostate epithelial cells via CRISPR inactivation of the CDKN2A locus and expression of telomerase. Prostate Cancer and Prostatic Diseases. 24(1). 233–243. 13 indexed citations
5.
Badal, Simone, Kerry S. Campbell, Henkel Valentine, & Camille Ragin. (2019). The need for cell lines from diverse ethnic backgrounds for prostate cancer research. Nature Reviews Urology. 16(12). 691–692. 8 indexed citations
6.
Badal, Simone, et al.. (2019). Disparities in prostate cancer incidence and mortality rates: Solvable or not?. The Prostate. 80(1). 3–16. 34 indexed citations
7.
Badal, Simone, et al.. (2017). Analysis of natural product regulation of opioid receptors in the treatment of human disease. Pharmacology & Therapeutics. 184. 51–80. 32 indexed citations
8.
Badal, Simone, Keriayn N. Smith, & Rajendram V. Rajnarayanan. (2017). Analysis of natural product regulation of cannabinoid receptors in the treatment of human disease. Pharmacology & Therapeutics. 180. 24–48. 21 indexed citations
9.
Badal, Simone, William Aiken, & Sheray N. Chin. (2017). Molecular Targets and Angiogenesis in Renal Cell Carcinoma, A Multitarget Approach: Mini Review. Current Drug Targets. 18(10). 7 indexed citations
10.
Badal, Simone, Malyn May Asuncion Valenzuela, George Q. Huang, et al.. (2017). Glaucarubulone glucoside from Castela macrophylla suppresses MCF‐7 breast cancer cell growth and attenuates benzo[a]pyrene‐mediated CYP1A gene induction. Journal of Applied Toxicology. 37(7). 873–883. 5 indexed citations
11.
Badal, Simone & Rupika Delgoda. (2013). CYP1B1: Friend OR Foe? A critical review. 1(1). 6 indexed citations
12.
Lowe, Henry, et al.. (2013). In Vitro Anticancer Activity of the Crude Extract and two Dicinnamate Isolates from the Jamaican Ball Moss (Tillandsia Recurvata L.).. PubMed. 3(1). 93–96. 13 indexed citations
13.
Badal, Simone, Winklet A. Gallimore, George Q. Huang, Tzuen‐Rong Tzeng, & Rupika Delgoda. (2012). Cytotoxic and potent CYP1 inhibitors from the marine algae Cymopolia barbata. PubMed. 2(1). 21–21. 22 indexed citations
14.
Badal, Simone, et al.. (2012). Antiproliferative activity and absolute configuration of zonaquinone acetate from the Jamaican alga Stypopodium zonale. Phytochemistry. 87. 96–101. 19 indexed citations
15.
Lowe, Henry, et al.. (2012). Cycloartane-3,24,25-triol inhibits MRCKα kinase and demonstrates promising anti prostate cancer activity in vitro. Cancer Cell International. 12(1). 46–46. 18 indexed citations
16.
Badal, Simone, et al.. (2010). Cytochrome P450 1 enzyme inhibition and anticancer potential of chromene amides from Amyris plumieri. Fitoterapia. 82(2). 230–236. 31 indexed citations
17.
Shields, Mario A., et al.. (2008). Inhibition of CYP1A1 by Quassinoids Found inPicrasma excelsa. Planta Medica. 75(2). 137–141. 26 indexed citations
18.
Brown, Paul D., et al.. (2006). Acute impairment of insulin signalling by dexamethasone in primary cultured rat skeletal myocytes. Molecular and Cellular Biochemistry. 297(1-2). 171–177. 13 indexed citations
19.
Badal, Simone, Paul Brown, & Dalip Ragoobirsingh. (2006). Nitric oxide agents impair insulin-mediated signal transduction in rat skeletal muscle. BMC Biochemistry. 7(1). 17–17. 6 indexed citations
20.
Badal, Simone, Paul Brown, & Dalip Ragoobirsingh. (2006). Exogenous nitric oxide inhibits IRS-1 expression in rat hepatocytes and skeletal myocytes. Journal of Biomedical Science. 13(4). 561–568. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026